/
/
/

Samrat Pharmachem Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)230.60
Volume (₹)145.00
High (₹)236.45
Upper Circuit248.65
Low (₹)230.00
Lower Circuit225.05
Prev Close236.85
52W High (₹)333.00
Price231.05
52W Low (₹)190.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)73.18 Cr
Div. Yield (%)0.00
PE Ratio0.00
Debt to Equity0.14
Price to Book1.35
Book Value232.39
EPS (TTM)-7.15
Face Value10.00
ROE (%)10.40

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
SAMRATPH-XNSE
LTP
1W Low
1W High
Market cap (₹)
1904.2-15.9 (-0.83%)
1901
1964.85
4,56,833Cr
9189-80 (-0.86%)
9051.85
9296
2,45,426Cr
4884.05-150.95 (-3.00%)
4884.05
5049
1,87,320Cr
1132.75-54.25 (-4.57%)
1126
1191.45
1,13,217Cr
1390-28 (-1.97%)
1377
1426.20
1,12,212Cr
1854.2-81.1 (-4.19%)
1812
1947.90
1,01,155Cr
2126-49 (-2.25%)
2117.80
2209
97,626Cr
2351-36.4 (-1.52%)
2323.15
2407.40
96,859Cr
1163-14.8 (-1.26%)
1155
1179.90
96,406Cr
1655.05+5.05 (0.31%)
1623.05
1706.70
93,614Cr
231.05-9.9 (-4.11%)
225
240.85
73Cr

Key Highlights of Samrat Pharmachem Ltd Balance Sheet

Samrat Pharmachem Ltd balance sheet discloses shareholders' funds of ₹3.09Cr as of 2025-03-31. The company’s equity share capital is at a value of ₹3.09Cr, and the reserves and surplus of the company is ₹68.71Cr.

The company has its non-current liabilities with total liabilities of ₹121.49Cr as of 2025-03-31.

The current liabilities are ₹49.58Cr as of 2025-03-31. At the same time, current assets are ₹103.36Cr as of 2025-03-31.

Key assets on the balance sheet are non-current investments of ₹3.44Cr and tangible assets of ₹10.48Cr, provided in the Samrat Pharmachem Ltd financial statements.